BIONEUTRA INTERNATIONAL LTD (TICKER SYMBOL: BIMO) MARIJUANA STOCK SOARS 207%
BioNeutra International Ltd. stock soars 207% after announcement of the company entering the medical marijuana market. Everyone knows that stocks in medical marijauana are soaring as they all position themselves into this new emerging market.
BioNeutra International Ltd. has very quickly positioned its self as a company with a much bigger vision than most companies by taking a global view of the emerging demand. Currently, with the exception of the national policy in place in Canada, the market is very fractured. Rules in every State are different and complex.
Deloitte, a well respected consulting firm, clearly states in a recent report that the current licensees will not be able to meet the demand over the next number of years.
To this end BioNeutra International Ltd is acquiring huge tracts of land for future growing operations. Originally we anticipated that our goal would be 5,000 acres which would make us the largest marijuana grow op in the world. However, we have upped that target to 10,000 acres. Properties are already being negotiated in the USA and Canada. We already have approximately 1500 acres negotiated.
With one of the medical marijuana licenses we are currently negotiating there is an export license attached which will allow us to export into all those countries that have recently legislated medical marijuana usage, such as Australia.
The recent rise of 207% in the value in our stock which is still in the pennies makes it a very attractive investment. As we move forward with what we feel will be very positive news we fully anticipate a significant appreciation.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: Certain information in this news release constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward- looking statements are often identified by terms such as “may”, “should”, “anticipate”, “expect”, “believe”, “intend” or the negative of these terms and similar expressions. Forward-looking statements in this news release include, but are not limited to, statements with respect to internal expectations, expected demand, estimated completion dates of capital projects, expectations of Health Canada approvals, expectations for future growing capacity, the completion of the capital project, any commentary related to the legalization of marijuana and the timing related thereto, expectations of Pharmacy’s entry into the medical and / or recreational cannabis industry and expectations with respect to future production costs. Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; marketing costs; loss of markets; future legislative and regulatory developments involving medical marijuana; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the medical marijuana industry in Canada generally, income tax and regulatory matters; the ability of BioNeutra International Ltd., to implement its business strategies; competition; crop failure; currency and interest rate fluctuations and other risks.
Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.